跳至主要内容
临床试验/NCT01289301
NCT01289301Unknown4 期

Polyomavirus BK Nephropathy After Renal Transplantation: Randomized Clinical Trial to Demonstrate That Switching to mTOR Inhibitor is More Effective Than a Reduction of Immunosuppressive Therapy

Hannover Medical School4 个研究点 分布在 1 个国家目标入组 124 人开始时间: 2011年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
124
试验地点
4
主要终点
death or graft loss

研究概览

简要总结

Polyomavirus BK nephropathy is a serious complication after renal transplantation leading to graft loss in 40% of cases. Since no virustatic drug exists, the investigators want to study the best way to manage viral invasion by changing the immunosuppressive treatment comparing two treatment schemes. The investigators hypothesis is that switching to an mTOR-based scheme is superior to a general decrease of a calcineurin inhibitor (CNI)-based scheme. The study will be performed as a prospective, randomized, parallel group comparison.

详细描述

The study group (n=62) will be switched from CNI to everolimus while the control group (n=62) will get a general reduction of the CNI-based immunosuppression. Follow-up and duration of intervention per patient will be 24 months, duration of the trial 72 months including 4 years of recruitment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • preceding renal transplantation
  • functioning graft with a permanent creatinine clearance of more than 25mL/min
  • biopsy-confirmed polyoma BK virus nephropathy
  • age over 18 years old

排除标准

  • allergy or non-tolerance of the study medication everolimus
  • pregnancy

研究组 & 干预措施

mTOR-receiving arm

Experimental

switching from calcineurin-inhibitor-based immunosuppression to mTOR-based immunosuppression

干预措施: mTOR inhibitor (everolimus) (Drug)

calcineurin-inhibitor keeping arm

Active Comparator

continuing calcineurin-inhibitor based immunosuppression

干预措施: cyclosporine or tacrolimus (Drug)

结局指标

主要结局

death or graft loss

时间窗: 2 years of observation

after experimental intervention (switch to mTOR inhibitor in group 1) and control intervention (general reduction of immunosuppression) observation of graft function

次要结局

  • decrease of polyomavirus serum PCR(2 years)
  • decrease of creatinine(2 years observation)
  • progression of chronic changes in renal histology(renal biopsy 3 months after intervention)
  • number of rejections following intervention(2 years after intervention)
  • increase of BKV-specific T-cells(2 years observation)

研究者

申办方类型
Other

研究点 (4)

Loading locations...

相似试验